Abstract
Purpose
Sarcoidosis is a multisystem disease that commonly affects the lung, eye, skin, and lymphatic systems. Organ function has been a major focus of treatment outcome with less attention given to more subjective impacts, such as health-related quality of life (HRQL). The purpose of this paper is to present a conceptual model of HRQL in sarcoidosis, which was developed through patient and clinician input.
Methods
We surveyed sarcoidosis clinical experts (n = 5) regarding disease-specific symptoms and their impact on their patient’s lives. We also conducted three sarcoidosis patient focus groups (n = 22) that reflected major sarcoidosis typologies (lung, skin, and eye). Data were coded and summarized using qualitative methodologies.
Results
Clinicians highlighted the following domains as being important (relative frequencies for comments are in parentheses): emotional distress (17 %), lung problems (14 %), pain (14 %), physical limitations (14 %), fatigue (10 %), social limitations (10 %), eye problems (7 %), skin problems (7 %), sleep disturbance (3 %), and constitutional symptoms (3 %). Similarly, patients highlighted the following domains: social limitations (14 %), skin problems (12 %), pain (10 %), coping (10 %), emotional distress (9 %), lung problems (8 %), eye problems (7 %), negative impact of corticosteroids (7 %), physical limitations(6 %), fatigue (6 %), sleep disturbance (3 %), constitutional symptoms (2 %), comorbidities (2 %), other systems affected (2 %), environmental factors (1 %), and positive impact of corticosteroids (1 %).
Conclusions
Clinician and patient responses overlapped in several domains, including emotional distress, physical and social limitations, and sarcoidosis-specific impacts, such as eye, skin, and lung problems. These findings support the HRQL impact of sarcoidosis and provide the basis for a conceptual model which has the potential to inform new patient-reported outcomes measures for this population.
Similar content being viewed by others
References
Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R., Cordier, J. F., du Bois, R., et al. (1999). ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vascular Diffuse Lung Disease, 16(2), 149–173.
Schilstra, A., Rottoli, P., Jacobs, J. A., van Suylen, R. J., Galluzzi, P., & Drent, M. (2006). Case studies to explore the pitfalls in the diagnosis of sarcoidosis. Sarcoidosis Vascular Diffuse Lung Disease, 23(2), 135–140.
De Vries, J., & Drent, M. (2007). Quality of life and health status in sarcoidosis: A review. Seminars in Respiratory Critical Care Medicine, 28(1), 121–127.
Viaene, E., Thomeer, M., Slabbynck, H., & Wuyts, W. (2012). Treatment strategies for sarcoidosis. Acta Clinica Belgica, 67(2), 83–87.
Judson, M. A. (2012). The treatment of pulmonary sarcoidosis. Respiratory Medicine, 106(10), 1351–1361.
De Vries, J., & Drent, M. (2006). Quality of life and health status in interstitial lung diseases. Current Opinion in Pulmonary Medicine, 12(5), 354–358.
Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P., & Judson, M. A. (2004). Health-related quality of life of persons with sarcoidosis. Chest, 125(3), 997–1004.
Cella, D. F. (1994). Quality of life: Concepts and definition. Journal of Pain and Symptom Management, 9(3), 186–192.
Victorson, D. E., Cella, D., & Judson, M. A. (2008). Quality of life evaluation in sarcoidosis: Current status and future directions. Current Opinion in Pulmonary Medicine, 14(5), 470–477.
Pariser, R. J., Paul, J., Hirano, S., Torosky, C., & Smith, M. (2012). A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis. Journal of American Academy and Dermatology, 68(5), 765–773.
Vucinic, V., Stojkovic, M., Milenkovic, B., Videnovic-Ivanov, J., Skodric-Trifunovic, V., Zugic, V., et al. (2012). Fatigue in sarcoidosis: Detection and treatment. Srpski Arhiv za Celokupno Lekarstvo, 140(1–2), 104–109.
Bourbonnais, J. M., Malaisamy, S., Dalal, B. D., Samarakoon, P. C., Parikh, S. R., & Samavati, L. (2012). Distance saturation product predicts health-related quality of life among sarcoidosis patients. Health Quality Life Outcomes, 10, 67.
Bourbonnais, J. M., & Samavati, L. (2010). Effect of gender on health related quality of life in sarcoidosis. Sarcoidosis Vascular Diffuse Lung Disease, 27(2), 96–102.
Saligan, L. N., Levy-Clarke, G., Wu, T., Faia, L. J., Wroblewski, K., Yeh, S., et al. (2010). Quality of life in sarcoidosis: Comparing the impact of ocular and non-ocular involvement of the disease. Ophthalmic Epidemiology, 17(4), 217–224.
Lazar, C. A., & Culver, D. A. (2010). Treatment of sarcoidosis. Seminars in Respiratory Critical Care Medicine, 31(4), 501–518.
De Vries, J., Lower, E. E., & Drent, M. (2010). Quality of life in sarcoidosis: Assessment and management. Seminars in Respiratory Critical Care Medicine, 31(4), 485–493.
Ware, J. E., Snow, K. K., & Kosinski, M. (2000). SF-36 health survey: Manual and interpretation guide. Lincoln, RI: QualityMetric Incorporated.
Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
Jones, P. W., Quirk, F. H., & Baveystock, C. M. (1991). The St. George’s Respiratory Questionnaire. Respiratory Medicine, 85(Suppl 2), 25–31.
Cox, C. E., Donohue, J. F., Brown, C. D., Kataria, Y. P., & Judson, M. A. (2003). The Sarcoidosis Health Questionnaire: A new measure of health-related quality of life. American Journal of Respiratory and Critical Care Medicine, 168(3), 323–329.
Heidegger, M. (1962). Being and time. New York: Harper & Row.
Walker, D., & Myrick, F. (2006). Grounded theory: An exploration of process and procedure. Qualitative Health Research, 16(4), 547–559.
Guba, E., & Lincoln, Y. (1985). Naturalist Inquiry. London: Sage.
Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Beverly Hills, CA: Sage.
Guba, E. G. (1978). Toward a methodology of naturalistic inquiry in education evaluation. Los Angeles: Center for the Study of Evaluation, UCLA Graduate School of Education, University of California, Los Angeles.
Auerswald, C. L., Greene, K., Minnis, A., Doherty, I., Ellen, J., & Padian, N. (2004). Qualitative assessment of venues for purposive sampling of hard-to-reach youth: An illustration in a Latino community. Sexually Transmitted Diseases, 31(2), 133–138.
Rybicki, B. A., Major, M., Popovich, J., Jr, Maliarik, M. J., & Iannuzzi, M. C. (1997). Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. American Journal of Epidemiology, 145(3), 234–241.
Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. New England Journal of Medicine, 357(21), 2153–2165.
Rybicki, B. A., & Iannuzzi, M. C. (2007). Epidemiology of sarcoidosis: Recent advances and future prospects. Seminars in Respiratory Critical Care Medicine, 28(1), 22–35.
Kendall, J. (1999). Axial coding and the grounded theory controversy. Western Journal of Nursing Research, 21(6), 743–757.
Guest, G., Bunce, A., & Johnson, L. (2006). How many interviews are enough? An experiment with data saturation and variability. Field Methods, 18(1), 59–82.
Bowen, G. A. (2008). Naturalistic inquiry and the saturation concept: A research note. Qualitative Research, 8(1), 137–152.
Earp, J. A., & Ennett, S. T. (1991). Conceptual models for health education research and practice. Health Education Research, 6(2), 163–171.
Bekhet, A. K., & Zauszniewski, J. A. (2012). Methodological triangulation: An approach to understanding data. Nurse Research, 20(2), 40–43.
Wilson, I. B., & Cleary, P. D. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. The Journal of the American Medical Association, 273(1), 59–65.
Victorson, D. E., Anton, S., Hamilton, A., Yount, S., & Cella, D. (2009). A conceptual model of the experience of dyspnea and functional limitations in chronic obstructive pulmonary disease. Value in Health, 12(6), 1018–1025.
Goracci, A., Fagiolini, A., Martinucci, M., Calossi, S., Rossi, S., Santomauro, T., et al. (2008). Quality of life, anxiety and depression in sarcoidosis. General Hospital Psychiatry, 30(5), 441–445.
Dogra, S., De, D., Radotra, B. D., Kanwar, A. J., & Pahwa, M. (2010). Atrophic sarcoidosis: An unusual presentation of cutaneous sarcoidosis. Skinmed, 8(1), 59–60.
Acknowledgments
This research was supported by J & J Pharmaceutical Services. The contents represent original work and have not been published elsewhere. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Victorson, D.E., Cella, D., Grund, H. et al. A conceptual model of health-related quality of life in sarcoidosis. Qual Life Res 23, 89–101 (2014). https://doi.org/10.1007/s11136-013-0438-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0438-1